<DOC>
<DOCNO>
EP-0011818
</DOCNO>
<TEXT>
<DATE>
19800611
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/63 A61K-31/635 A61P-5/38 A61K-31/57 A61P-5/00 <main>A61K-45/06</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
medicaments and pharmaceutical compositions based on aldosterone antagonists and diuretics and process for their manufacture.
</TITLE>
<APPLICANT>
ciba geigy agch<sep>ciba-geigy ag<sep>ciba-geigy agklybeckstrasse 1414002 baselch<sep>ciba-geigy ag <sep>
</APPLICANT>
<INVENTOR>
biollaz michel dr<sep>biollaz, michel, dr.<sep>biollaz, michel, dr.morystrasse 2ch-4125 riehench<sep>biollaz, michel, dr.<sep>biollaz, michel, dr.morystrasse 2ch-4125 riehench<sep>
</INVENTOR>
<ABSTRACT>
A favorable diuretic effect by excretioning water, sodium and chloride ions at reduced excretion of potassium ions can be achieved by combined administration of a 19-oxygenated steroidal compound of the pregnan series of the formula wherein Ra is a hydrogen atom and RB an α-oriented never deralkanoylthio group means or Ra and Rb together for a carbon carbon bond or for an α- or β-oriented methylene residue, R represents a free or by a lower alkyl etherest or by a Lower Alkalka nooyly hydroxymethyl group, a formyl group, a carboxyl group or a lower alkoxycarbonyl group and R² hydrogen or the acyl radical AC of a car bonsic acid, as the aldosterone-antagonizing component A, on the one hand and a conventional diuretism, e.g. b. a diuretically effective derivative of benzothiadia zin, benzenesulfonamide, phenoxyacetic acid, benzofuran-2 carboxylic acid or 2,3-dihydrobenzofuran-2-carboxylic acid, as component B on the other hand. The two components A and B can be administered separately or together as a corresponding composition or medicament.
</ABSTRACT>
</TEXT>
</DOC>
